newsfilter
← Latest News
Business Wire·

Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th

Cortexyme, Inc. (NASDAQ:CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Casey Lynch, chief executive offi